KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.1090
+0.0039 (3.71%)
At close: May 1, 2026, 4:00 PM EDT
0.1131
+0.0041 (3.76%)
After-hours: May 1, 2026, 7:57 PM EDT
KALA BIO Employees
KALA BIO had 6 employees as of December 31, 2025. The number of employees decreased by 32 or -84.21% compared to the previous year.
Employees
6
Change (1Y)
-32
Growth (1Y)
-84.21%
Revenue / Employee
n/a
Profits / Employee
-$4,496,667
Market Cap
101.31M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6 | -32 | -84.21% |
| Dec 31, 2024 | 38 | -5 | -11.63% |
| Dec 31, 2023 | 43 | 9 | 26.47% |
| Dec 31, 2022 | 34 | -158 | -82.29% |
| Dec 31, 2021 | 192 | 4 | 2.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cibus | 118 |
| Inovio Pharmaceuticals | 112 |
| Fractyl Health | 100 |
| Pyxis Oncology | 56 |
| Biomea Fusion | 41 |
| Oncolytics Biotech | 29 |
| ProMIS Neurosciences | 11 |
| Coya Therapeutics | 8 |
KALA News
- 11 days ago - Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine - GlobeNewsWire
- 4 weeks ago - Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities - GlobeNewsWire
- 4 weeks ago - KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live - GlobeNewsWire
- 4 weeks ago - EXCLUSIVE: Penny Stock Kala Bio Transitions To Revenue Model With AI Platform Launch - Benzinga
- 6 weeks ago - Red Light Holland Engages Kala Bio's Researgency.AI Platform to Support Clinical Development of Filament's Patented PEX010 Botanical Psilocybin Drug Candidate - GlobeNewsWire
- 6 weeks ago - Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate - Newsfile Corp
- 7 weeks ago - Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents - Newsfile Corp
- 7 weeks ago - Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates - GlobeNewsWire